Literature DB >> 11835636

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era.

Fenwei Wang1, George A Stouffer, Sergio Waxman, Barry F Uretsky.   

Abstract

The incidence of coronary stent thrombosis is < 1%-2% in recent studies, with the highest-risk period considered to be the first 30 days following stent implantation. Recently, stent thrombosis after 30 days has been reported in patients undergoing brachytherapy with stenting. We reviewed the incidence of stent thrombosis causing myocardial infarction in nonbrachytherapy patients at our institution between 1 January 1996 and 30 November 1999. A case control methodology was employed with a 1:3 ratio of stent thrombosis to control patients. Of 1,191 patients undergoing coronary stenting, acute (< 24 hr) plus subacute (1-30 days) stent thrombosis occurred in 0.92% (11 of 1,191 patients). A further 0.76% (9 of 1,191 patients) developed late stent thrombosis after 30 days. There were no clinical or angiographic features at the time of the initial procedure that were associated with stent thrombosis as an entire group compared with control group, but early (acute and subacute) stent thrombosis patients had a smaller final stent minimal lumen diameter and longer stent length compared with patients who had late stent thrombosis or controls. Late stent thrombosis occurs in nonbrachytherapy patients and is almost as frequent as early stent thrombosis. Further studies are required to determine whether longer-term poststent pharmacological treatment may decrease or prevent this complication. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835636     DOI: 10.1002/ccd.10041

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

1.  Very late thrombosis after implantation of sirolimus eluting stent.

Authors:  E Karvouni; S Korovesis; D G Katritsis
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  Simultaneous angiographic late stent thrombosis in two different coronary vessels after withdrawal of the combined anti-platelet therapy.

Authors:  Jürgen Kammler; Robert Hofmann; Clemens Steinwender; Alexander Kypta; Franz Leisch
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

3.  Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment.

Authors:  Gordon E Pate; May Lee; Karin Humphries; Eric Cohen; Robert Lowe; Rebecca S Fox; Robert Teskey; Christopher E Buller
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

4.  Late adverse events after drug-eluting stent implantation.

Authors:  David F Kong; Eric L Eisenstein; Robert Harrington
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

Review 5.  Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Authors:  J Carlsson; B von Wagenheim; R Linder; T M Anwari; J Qvist; I Petersson; T Magounakis; B Lagerqvist
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

6.  Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction.

Authors:  Inthirai Somasuntharam; Kevin Yehl; Sheridan L Carroll; Joshua T Maxwell; Mario D Martinez; Pao-Lin Che; Milton E Brown; Khalid Salaita; Michael E Davis
Journal:  Biomaterials       Date:  2015-12-21       Impact factor: 12.479

Review 7.  Drug-eluting stents: insights into safety and indications.

Authors:  Walid Hassan
Journal:  Ann Saudi Med       Date:  2008 Mar-Apr       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.